Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral ibuprofen versus fluid restriction for patent ductus arteriosus in preterm infants
IRCT2013071113022N2Phase 2Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoints: Short-term complications of treatment and Long-term complications of treatment. Started Jan 2013; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT2013071113022N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013071113022N2.